comparing liraglutide 1.2 mg/day + metformin 1000 mg BID combination therapy and liraglutide 1.2 mg/day alone in nondiabetic women with PCOS and obesity, again despite a significant improvement in anthropometric parameters in both groups, the combined therapy was associated with a significant reduction in fasting and 120 min glucose levels during OGTT [60]
This two-step engagement is why truncating the N-terminus abolishes activation while leaving binding partly intact, and it is why the position-8 modification can block a protease without destroying agonism: the residue is inside the activating segment but is tolerant of substitution
For many patients, a better metabolic plan means fewer cravings, more stable energy, improved health markers, and a more realistic path to long-term weight control
Ahead, TZR talked to the experts to answer some of your biggest questions around GLP-1s and hair loss, so you can better understand what to expect and, most importantly, what you can do about it
Good news
This discovery provides an essential mechanistic blueprint to explain why patient responses vary, why weight loss eventually plateaus, and how combining treatments could extend drug efficacy